Oramed Pharmaceuticals Inc (ORMP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -25.705 | -29.56 | -34.987 | -29.033 | -28.948 | -10.49 | -25.246 | 2.891 |
Return on Equity (%) | -46.139 | -50.554 | -56.846 | -44.043 | -33.451 | -11.698 | -27.318 | 3.519 |
Return on Invested Capital (%) | -144.59 | -173.442 | -90.911 | -50.02 | -42.603 | -14.802 | -34.902 | -12.372 |
Operating Margin (%) | -406.311 | -515.476 | -503.7 | -408.598 | -924.195 | -1346.018 | -1363.078 | 661.269 |
Net Profit Margin (%) | -426.71 | -519.682 | -531.077 | -424.76 | -924.417 | -1290.708 | -1352.608 | 412.313 |
Book Value Per Share | 0.192 | 0.3 | 0.187 | 0.298 | 0.957 | 1.336 | 1.199 | 1.284 |
Earnings Per Share | -0.105 | -0.123 | -0.138 | -0.104 | -0.205 | -0.094 | -0.29 | 0.044 |
Cash Per Share | 0.04 | 0.048 | 0.032 | 0.175 | 0.634 | 0.22 | 0.321 | 0.071 |
Working Capital Per Share | 0.151 | 0.255 | 0.27 | 0.327 | 0.728 | 1.128 | 1.201 | 0.862 |
Operating Profit Per Share | 0.023 | 0.024 | 0.025 | 0.025 | 0.022 | 0.007 | 0.021 | 0.013 |
EBIT Per Share | -0.101 | -0.123 | -0.135 | -0.104 | -0.205 | -0.098 | -0.299 | 0.04 |
EBITDA Per Share | -0.101 | -0.123 | -0.135 | -0.104 | -0.205 | -0.098 | -0.299 | 0.04 |
Free Cash Flow Per Share | -0.105 | -0.123 | -0.138 | -0.104 | -0.203 | -0.094 | -0.287 | 0.044 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 13,67M | 17,37M | 17,38M | 23,68M | 35,29M | 38,16M | 39,56M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 39,56M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -542.192 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -509.76 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 88,28M |
Ratio cours/bénéfice | 15,97 |
Ratio prix/ventes | 54,21 |
Ratio prix/liquidités | 9,75 |
Ratio prix/valeur comptable | 0,54 |
Rendement de dividende | - |
Actions en circulation | 40,31M |
Volume moyen (1 semaine) | 97,03k |
Volume moyen (1 mois) | 115k |
Variation sur 52 semaines | -19,49% |
Plus haut sur 52 semaines | 3,67 |
Plus bas sur 52 semaines | 2,00 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales